Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 17;14(1):21645.
doi: 10.1038/s41598-024-69252-3.

A retrospective analysis suggests PTEN expression is associated with favorable clinicopathological features of breast cancer

Leonard Derkyi-Kwarteng  1 , Frank Naku Ghartey  2 , Eric Aidoo  3 , Ernest Addae  1 , Emmanuel Gustav Imbeah  1 , Ato Ampomah Brown  3 , Samuel Acquah  4
Affiliations

A retrospective analysis suggests PTEN expression is associated with favorable clinicopathological features of breast cancer

Leonard Derkyi-Kwarteng et al. Sci Rep. .

Abstract

The phosphatase and tensin homolog (PTEN) gene acts as a tumor suppressor by regulating the PI3K/AKT pathway, crucial for cell growth and survival. Mutations or loss of PTEN are common in breast cancer, leading to uncontrolled cell growth. Understanding PTEN's role is vital for targeted therapies. 276 formalin-fixed paraffin-embedded (FFPE) breast cancer tissue blocks from 2012 to 2016 were analyzed for PTEN expression. Immunohistochemistry was performed to identify and assess tumor related clinicopathological characteristics as well as patient demographics. These were statistically matched with PTEN expression. Only 27.5% of the breast cancer tumors were PTEN-positive. PTEN expression correlated significantly with smaller tumor size, lower tumor grade, positive estrogen and progesterone receptor status, and favorable/unfavorable Ki67 status (p < 0.001). No significant association was found with vascular invasion, histologic type, age, HER2 status, staging, or lymph node involvement (p > 0.05). The study confirms PTEN's association with favorable clinicopathological features in breast cancer, supporting its role as a prognostic marker. These findings underscore the importance of PTEN in breast cancer biology and its potential as a therapeutic target. Furthermore these findings confirm the prevalence of advanced stage and aggressive breast cancer tumors in Ghana.

Keywords: Archival samples; Breast carcinoma; Clinicopathological characteristics; Favorable prognosis; PTEN expression; Retrospective analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Heikkinen, T. et al. Variants on the promoter region of PTEN affect breast cancer progression and patient survival. Breast Cancer Res.13, 1–11 (2011). - PMC - PubMed
    1. Chu, E. C. & Tarnawski, A. S. PTEN regulatory functions in tumor suppression and cell biology. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.10(10), 235–241 (2004). - PubMed
    1. Lin Fde, M. et al. Loss of PTEN expression and AKT activation in HER2-positive breast carcinomas. Rev. Bras. Ginecol. Obstet.36(8), 340–346 (2014). - PubMed
    1. Maiques, O. et al. Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues. Hum. Pathol.45(3), 522–532 (2014). - PubMed
    1. Tsou, H. C. et al. The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am. J. Hum. Genet.61(5), 1036–1043 (1997). - PMC - PubMed